Skip to content
Study details
Enrolling now

Magnetic Resonance (MR) Imaging for Brain Tumors

Memorial Sloan Kettering Cancer Center
NCT IDNCT00870129ClinicalTrials.gov data as of Apr 2026
Target enrollment

135

Study length

about 18 years

Ages

18+

Locations

1 site in NY

What this study is about

This trial is testing whether advanced MR imaging can help identify high-risk areas in malignant gliomas. The researchers are examining the safety of this advanced imaging technique and looking for any side effects in people with brain tumors.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Undergo MRI and advanced MRI sequences

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: To assess the utility of baseline advanced MRI & changes between baseline & follow up advanced MRI in predicting high risk areas that are likely to develop progressive glioma despite chemoradiotherapy.

Secondary: To compare radiation therapy simulations in patients with gliomas using conventional and baseline advanced MRI data.

Procedures

imaging